Total elimination of measles in Finland

References

• Chen R T, Moldau G M, Wassilak S GF, Markowitz L E, Orenstein W A. An explosive point-source measles outbreak in a highly vaccinated population. Am J Epidemiol 1989; 129: 173–82
   PubMed Web of Science ®Google Scholar
• Peltola H, Karanko V, Kurki T, et al. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986; 1: 137–9
   PubMed Web of Science ®Google Scholar
• Weibel R E, Carlson A J, Jr, Villarejos V M, et al. Clinical and laboratory studies on combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proc Soc Exp Biol Med 1980; 165: 323–6
   PubMed Web of Science ®Google Scholar
• Peltola H, Heinonen O P, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331: 1397–402
   PubMed Web of Science ®Google Scholar
• Peltola H, Heinonen O P. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind, placebo-controlled trial in twins. Lancet 1986; 1: 939–42
   PubMed Web of Science ®Google Scholar
• Juntunen-Backman K, Peltola H, Backman A, Salo O P. Safe immunization of allergic children against measles, mumps and rubella. Am J Dis Child 1987; 141: 1103–5
   PubMedGoogle Scholar
• Paunio M, Virtanen M, Peltola H, et al. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol 1991; 133: 1152–60
   PubMed Web of Science ®Google Scholar
• Nieminen U, Peltola H, Syrjälä M T, Mäkipernaa A, Kekomäki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr 1993; 82: 267–70
   PubMed Web of Science ®Google Scholar
• Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 1995; 13: 1617–22
   PubMed Web of Science ®Google Scholar
• Tait D R, Ward K N, Brown D WG, Miller E. Measles and rubella misdiagnosed in infants as exanthem subitum (roseola infantum). BMJ 1996; 312: 101–2
   PubMedGoogle Scholar
• Peltola H, Davidkin I, Valle M, et al. No measles in Finland. Lancet 1997; 350: 1364–5
   PubMed Web of Science ®Google Scholar
• Valmari P, Lanning P, Tuokko H, Kouvalainen K. Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatr Infect Dis J 1987; 6: 59–63
   PubMedGoogle Scholar
• Foege W H. Measles vaccination in Africa. Proceedings of the International Conference on the Application of Vaccines Against Viral, Rickettsial, and Bacterial Diseases of Man. Pan American Health Organization, Washington, DC 1971; 207–12, Scientific publication 226
   Google Scholar
• Dittmann S, Starke G, Odelitz H W, et al. The measles eradication programme in the German Democratic Republic. Bull WHO 1976; 53: 21–4
   PubMedGoogle Scholar
• de Quadros C A, Olive J, Hersh B S, et al. Measles elimination in the Americas. Evolving strategies. JAMA 1996; 275: 224–9
   PubMed Web of Science ®Google Scholar
• Expanded Programme on Immunization (EPI) measles and the interruption of indigenous transmission, 1996. Wkly Epidemiol Rec 1997; 72: 181–4
   PubMedGoogle Scholar
• Panum P L. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Classics 1939; 3: 829–86
   Google Scholar
• Paunio M, Peltola H, Valle M, Virtanen M, Cantell K, Heinonen O P (1996) Two vaccine doses more protective than one dose against epidemic measles. Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy Abstract H62 ICAAC, New Orleans, LO, Sept 15–18, 1996. American Society for Microbiology, Washington, DC
   Google Scholar
• Reyes M A, de Borrero M F, Roa J, Bergonzoli G, Saraviak N G. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987; 6: 848–51
   PubMed Web of Science ®Google Scholar
• Mathias R G, Meekison W G, Arcand T A, Schehter M T. The role of secondary vaccine failure in measles outbreaks. Am J Public Health 1989; 79: 475–8
   PubMed Web of Science ®Google Scholar